J&J and the rest of the pharmaceutical industry have seized on the coronavirus crisis as a way to polish an image tarnished by unaffordable medicine, patent lawsuits and an addiction epidemic.
Americans must have a say in the price.
Johnson & Johnson stands to turn a pandemic into a payday at the expense of taxpayers.
Upon closer look, J&J stands to profit handsomely.
"The price hike coincides with the company's push to get its drug to more patients — specifically those diagnosed with COVID-19."
Drug companies only showed interest in COVID-19 vaccines and treatments when huge profits arose.
The federal government will be the single largest investor and the largest purchaser of an upcoming COVID-19 vaccine or treatment.